Related references
Note: Only part of the references are listed.FGFR-targeted gene delivery mediated by supramolecular assembly between β-cyclodextrin-crosslinked PEI and redox-sensitive PEG
Yuan Ping et al.
BIOMATERIALS (2013)
Strategies for Overcoming Acquired Resistance to Epidermal Growth Factor Receptor-Targeted Therapies in Lung Cancer
Geoffrey R. Oxnard
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
Nanocarriers for the Simultaneous Co-Delivery of Therapeutic Genes and Anticancer Drugs
Nazia N. Choudhury et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Therapeutic live vaccines as a potential anticancer strategy
Azam Bolhassani et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Julian R. Molina et al.
MAYO CLINIC PROCEEDINGS (2012)
Combining immunotherapy and targeted therapies in cancer treatment
Matthew Vanneman et al.
NATURE REVIEWS CANCER (2012)
Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery
Yuan Ping et al.
BIOMATERIALS (2011)
New Strategies in Overcoming Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer
Geoffrey R. Oxnard et al.
CLINICAL CANCER RESEARCH (2011)
Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression
Hong-Yi Huang et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2011)
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
Vinod P. Balachandran et al.
NATURE MEDICINE (2011)
Immune parameters affecting the efficacy of chemotherapeutic regimens
Laurence Zitvogel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Functionalization of Chitosan via Atom Transfer Radical Polymerization for Gene Delivery
Yuan Ping et al.
ADVANCED FUNCTIONAL MATERIALS (2010)
Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-γ-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector
Hongliang Huang et al.
BIOMATERIALS (2010)
Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers
Caihong Zhu et al.
BIOMATERIALS (2010)
Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome
Wenjing Xiao et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Co-delivery of as-miR-21 and 5-FU by Poly(amidoamine) Dendrimer Attenuates Human Glioma Cell Growth in Vitro
Yu Ren et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2010)
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
Carsten Denkert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Combined treatment with TNF-α/gefitinib alleviates the resistance to gefitinib in PC-9 cells
Yuan Ji et al.
ANTI-CANCER DRUGS (2009)
The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles
Ashlynn L. Z. Lee et al.
BIOMATERIALS (2009)
Co-delivery of Doxorubicin and Bcl-2 siRNA by Mesoporous Silica Nanoparticles Enhances the Efficacy of Chemotherapy in Multidrug-Resistant Cancer Cells
Alex M. Chen et al.
SMALL (2009)
Tumor-Infiltrating Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Patients with Breast Carcinoma
Helena Hornychova et al.
CANCER INVESTIGATION (2008)
Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer:: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy
Aristotelis Bamias et al.
GYNECOLOGIC ONCOLOGY (2008)
Low molecular weight polyethylenimines linked by β-cyclodextrin for gene transfer into the nervous system
G. P. Tang et al.
JOURNAL OF GENE MEDICINE (2006)
Efficacy and safety of gefitinib in chemonaive patients with advanced non-small cell lung cancer treated in an Expanded Access Program
Ramaswamy Govindan et al.
LUNG CANCER (2006)
Synergistic antitumor activity of cisplatin, paclitaxel, and gemcitabine with tumor vasculature-targeted tumor necrosis factor-alpha
A Sacchi et al.
CLINICAL CANCER RESEARCH (2006)
Two novel non-viral gene delivery vectors: low molecular weight polyethylenimine cross-linked by (2-hydroxypropyl)-beta-cyclodextrin or (2-hydroxypropyl)-gamma-cyclodextrin
Hongliang Huang et al.
CHEMICAL COMMUNICATIONS (2006)
Enhancement of sensitivity to tumor necrosis factor α in non-small cell lung cancer cells with acquired resistance to gefitinib
K Ando et al.
CLINICAL CANCER RESEARCH (2005)
Gefitinib in non-small cell lung cancer
K Tamura et al.
EXPERT OPINION ON PHARMACOTHERAPY (2005)
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib
EL Kwak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
S Kobayashi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
W Pao et al.
PLOS MEDICINE (2005)
In vitro biological activities of transmembrane superantigen staphylococcal enterotoxin A fusion protein
WX Ma et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Escape from immunotherapy: possible mechanisms that influence tumor regression/progression
M Ahmad et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Cytokines in cancer pathogenesis and cancer therapy
G Dranoff
NATURE REVIEWS CANCER (2004)
Cyclodextrin-based pharmaceutics: Past, present and future
ME Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Regulation of tumor growth by IFN-gamma in cancer immunotherapy
GL Beatty et al.
IMMUNOLOGIC RESEARCH (2001)
Share Paper
